AGILE THERAPEUTICS INC Quarterly Common Stock, Shares, Issued from Q4 2013 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Agile Therapeutics Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q2 2024.
  • Agile Therapeutics Inc Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 6.9M shares, a 321% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 6.9M +5.26M +321% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 6.86M +5.92M +636% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 2.96M +2.1M +245% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 2.28M -36.7M -94.2% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 1.64M -10.7M -86.7% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 932K -2.43M -72.3% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 859K -2.18M -71.7% Dec 31, 2022 10-K 2024-03-28
Q3 2022 39M -55.7M -58.8% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 12.4M -80.6M -86.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 3.37M -84.9M -96.2% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 3.03M -84.5M -96.5% Dec 31, 2021 10-K 2023-03-23
Q3 2021 94.7M +7.29M +8.34% Sep 30, 2021 10-Q/A 2021-12-30
Q2 2021 92.9M +5.63M +6.45% Jun 30, 2021 10-Q 2021-07-26
Q1 2021 88.3M +1.05M +1.21% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 87.6M +17.8M +25.4% Dec 31, 2020 10-K 2022-03-30
Q3 2020 87.4M +28.1M +47.4% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 87.3M +42.7M +95.6% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 87.2M +43.6M +100% Mar 31, 2020 10-Q 2020-05-05
Q4 2019 69.8M +35.4M +103% Dec 31, 2019 10-K 2021-03-01
Q3 2019 59.3M +24.9M +72.5% Sep 30, 2019 10-Q 2019-10-28
Q2 2019 44.6M +10.3M +29.8% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 43.6M +9.37M +27.4% Mar 31, 2019 10-Q 2019-05-03
Q4 2018 34.4M +191K +0.56% Dec 31, 2018 10-K 2020-02-20
Q3 2018 34.4M +219K +0.64% Sep 30, 2018 10-Q 2018-11-02
Q2 2018 34.4M +5.57M +19.3% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 34.2M +5.47M +19% Mar 31, 2018 10-Q 2018-05-07
Q4 2017 34.2M +5.43M +18.9% Dec 31, 2017 10-K 2019-03-12
Q3 2017 34.2M +5.4M +18.8% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 28.8M +53.7K +0.19% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 28.8M +38.3K +0.13% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 28.8M +6.44M +28.9% Dec 31, 2016 10-K 2018-03-12
Q3 2016 28.8M +6.47M +29% Sep 30, 2016 10-Q 2016-11-07
Q2 2016 28.8M +6.51M +29.3% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 28.7M +6.58M +29.7% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 22.3M +3.68M +19.8% Dec 31, 2015 10-K 2017-03-15
Q3 2015 22.3M +3.69M +19.9% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 22.2M +3.64M +19.6% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 22.2M Mar 31, 2015 10-Q 2015-05-12
Q4 2014 18.6M +18.5M +16946% Dec 31, 2014 10-K 2016-03-09
Q3 2014 18.6M Sep 30, 2014 10-Q 2014-11-13
Q2 2014 18.6M Jun 30, 2014 10-Q 2014-08-14
Q4 2013 109K Dec 31, 2013 10-K 2015-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.